Amedeo Smart

Free Medical Literature Service

 

Amedeo

Autoimmune Disorders
  Free Subscription

Articles published in
Curr Opin Immunol
    June 2026
  1. MOUTSOPOULOS HM, Cinoku II, Mavragani CP
    Raynaud's phenomenon: a vascular or an autoimmune-mediated disorder? Facts and fancy.
    Curr Opin Immunol. 2026;101:102803.
    >> Share

  2. TONUTTI A, D'Amico S, Timilsina S, Gershwin ME, et al
    Use of synthetic data, a novel paradigm for immunopathology.
    Curr Opin Immunol. 2026;100:102753.
    >> Share

  3. PERICLEOUS C, Strauss E, Arachchillage DJ
    Endothelial dysfunction in APS: advancing pathophysiological understanding to improve management.
    Curr Opin Immunol. 2026;100:102745.
    >> Share

    May 2026
  4. CAMERA M, Tremoli E, Lonati PA, Meroni PL, et al
    Novel mechanisms linking platelet activation to antiphospholipid syndrome.
    Curr Opin Immunol. 2026;101:102791.
    >> Share

  5. ARACHCHILLAGE DJ, Efthymiou M, Cohen H
    The role of different aPL subpopulations in the lupus anticoagulant phenomenon.
    Curr Opin Immunol. 2026;100:102784.
    >> Share

    April 2026
  6. SURESH SC, Furie R, Narain S
    Outcome measures in systemic lupus erythematosus.
    Curr Opin Immunol. 2026;100:102782.
    >> Share

  7. SEVIM E, Erton ZB, Erkan D
    Understanding antiphospholipid syndrome clinical phenotypes with the guidance of antiphospholipid antibody-related pathogenic mechanisms.
    Curr Opin Immunol. 2026;100:102770.
    >> Share

  8. FUJIEDA Y, Amengual O, Meroni PL, Atsumi T, et al
    Hot topics in the antiphospholipid syndrome.
    Curr Opin Immunol. 2026;100:102775.
    >> Share

  9. KIROU KA, Kirou RA, Flouda S
    New developments and future directions in the management of systemic lupus erythematosus.
    Curr Opin Immunol. 2026;100:102774.
    >> Share

  10. MARTINEZ T, Grand Z, Garcia S, Rockwell M, et al
    A global perspective on autoimmunity and immunodeficiency: exploring geoepidemiology trends.
    Curr Opin Immunol. 2026;100:102773.
    >> Share

  11. KUMAR S, Ponzar N, Pozzi N
    beta(2)-Glycoprotein I: structure, mechanisms of autoantibody recognition, and polymorphisms.
    Curr Opin Immunol. 2026;100:102771.
    >> Share

  12. KIRINO Y, Takeno M
    A critical look at animal and cellular models in autoinflammatory diseases.
    Curr Opin Immunol. 2026;99:102719.
    >> Share

    March 2026
  13. MATHEOUD D, Akbar I, Hercun J, Stratton JA, et al
    A liver-mitochondria-immune axis in Parkinson's disease: emerging perspectives on a hepatic origin for mitochondrial autoimmunity as a driver of Parkinson's disease.
    Curr Opin Immunol. 2026;100:102761.
    >> Share

  14. YALAVARTHI S, NaveenKumar SK, Knight JS
    Neutrophils and monocytes in the pathogenesis of antiphospholipid syndrome.
    Curr Opin Immunol. 2026;100:102768.
    >> Share

  15. RENAUDINEAU Y, Brooks W
    P2 purinergic receptors in systemic lupus erythematosus: from experimental findings to therapeutic perspectives.
    Curr Opin Immunol. 2026;100:102752.
    >> Share

  16. GROSSI C, Buckle II, McDonnell TC
    Autoimmunity beyond antibodies: alternative roles of beta-2-glycoprotein I in and out of antiphospholipid syndrome?
    Curr Opin Immunol. 2026;100:102748.
    >> Share

    February 2026
  17. JULIAN VELASCO-LANCHEROS O, Acosta-Ampudia Y, Monsalve DM, Ramirez-Santana C, et al
    Mpox virus immunology: exploring links to autoimmune diseases.
    Curr Opin Immunol. 2026;99:102744.
    >> Share

  18. ALTINTAS A, Bulus E
    Multiple sclerosis: a disease or a syndrome?
    Curr Opin Immunol. 2026;99:102736.
    >> Share

  19. MEGHASHYAM S, Serajee FJ, Prakash AV, Altinok D, et al
    Primary angiitis of the central nervous system.
    Curr Opin Immunol. 2026;98:102691.
    >> Share

    January 2026
  20. ELSAGHIR A, Witte T
    New autoantibodies in Sjogren's disease.
    Curr Opin Immunol. 2026;99:102722.
    >> Share

    December 2025
  21. YANG T, Goudarzi N, Kroese FGM, Mariette X, et al
    Salivary gland organoids and the future of modeling autoimmune epithelitis in Sjogren's disease.
    Curr Opin Immunol. 2025;98:102707.
    >> Share

    November 2025
  22. SWEENEY N, Atisha-Fregoso Y, Pozovskiy R, Higdon L, et al
    Can we cure autoimmunity?
    Curr Opin Immunol. 2025;98:102684.
    >> Share

    October 2025
  23. ROJAS M, Acosta-Ampudia Y, Monsalve DM, Rami?rez-Santana C, et al
    Autoimmunity, epitope analysis, and molecular mimicry.
    Curr Opin Immunol. 2025;97:102681.
    >> Share

  24. CLEMENT TL, Cohen PL
    Can we cure lupus?
    Curr Opin Immunol. 2025;96:102640.
    >> Share

  25. MAHARAJ S, Chang C
    Can juvenile idiopathic arthritis be cured?
    Curr Opin Immunol. 2025;96:102632.
    >> Share

  26. SULLIVAN JK, Kwun A, Jorgensen TN
    Neuropsychiatric lupus: a myriad of symptoms requires a myriad of models.
    Curr Opin Immunol. 2025;96:102631.
    >> Share

  27. FREE ME, Ciavatta DJ, Falk RJ
    Can we cure vasculitis?
    Curr Opin Immunol. 2025;96:102618.
    >> Share

    September 2025
  28. CLAVARINO G, Vigne J, Meuleman MS, Amen A, et al
    Complement in systemic lupus erythematosus across time and space: from tolerance to tissue injury and from extracellular to intracellular functions.
    Curr Opin Immunol. 2025;97:102655.
    >> Share

    August 2025
  29. MOSELEY CE, Sabatino JJ Jr, Zamvil SS
    B-cell antigen presentation in central nervous system autoimmunity.
    Curr Opin Immunol. 2025;96:102647.
    >> Share

  30. HU Z, Zhao M
    B cell-targeted therapies in autoimmune skin disease: current advances and challenges.
    Curr Opin Immunol. 2025;96:102643.
    >> Share

  31. DRAGON DUREY MA, Hamidi H, Darnige L
    Complement in antiphospholipid syndrome, time to target?
    Curr Opin Immunol. 2025;96:102628.
    >> Share

  32. MERONI PL, Capobianco E, Tedesco F
    Can we cure antiphospholipid syndrome?
    Curr Opin Immunol. 2025;96:102610.
    >> Share

  33. CETIN GEDIK K, Casares-Marfil D, Demirkaya E, Sawalha AH, et al
    The role of epigenetic modifications in systemic autoinflammatory diseases.
    Curr Opin Immunol. 2025;95:102599.
    >> Share

  34. XU C, Shen Y, Wang Q, Zhu H, et al
    Immunotherapy for pemphigus and bullous pemphigoid.
    Curr Opin Immunol. 2025;95:102591.
    >> Share

  35. LIU S, Lu Q
    Can we cure bullous skin diseases?
    Curr Opin Immunol. 2025;95:102589.
    >> Share

  36. OKAZAKI K, Ikeura T, Uchida K
    'Can we cure IgG4-related diseases?'.
    Curr Opin Immunol. 2025;95:102564.
    >> Share

    July 2025
  37. LIN SL, Carroll MC
    Neuroimmune mechanisms of neuropsychiatric systemic lupus erythematosus.
    Curr Opin Immunol. 2025;96:102608.
    >> Share

  38. LONGHI MS, Zhang L, Mieli-Vergani G, Vergani D, et al
    Can we cure autoimmune hepatitis?
    Curr Opin Immunol. 2025;96:102609.
    >> Share

  39. DEI ZOTTI F, Hudson KE
    Development and consequences of red blood cell autoantibodies: warm autoimmune hemolytic anemia.
    Curr Opin Immunol. 2025;95:102604.
    >> Share

  40. FAN S, Pruss H
    Pathogenic mechanisms of autoantibodies in neurological autoimmune diseases.
    Curr Opin Immunol. 2025;95:102594.
    >> Share

  41. XU Y, Yi X, Li C, Chen J, et al
    CD8(+)T cell exhaustion: the potential for treating autoimmune diseases.
    Curr Opin Immunol. 2025;95:102600.
    >> Share

    June 2025
  42. NIE W, Yang X, Ma M, Xu X, et al
    Chimeric antigen receptor T cell therapy for autoimmune diseases.
    Curr Opin Immunol. 2025;95:102596.
    >> Share

  43. DAI M, Mei B, Zheng F, Ballestar E, et al
    Sex hormones and epigenetic dysregulation in autoimmune disease.
    Curr Opin Immunol. 2025;95:102595.
    >> Share

  44. ZHOU W, Zhang B, Zhao M, Lu Q, et al
    Epigenetics: the link between environmental exposures and autoimmune diseases.
    Curr Opin Immunol. 2025;95:102592.
    >> Share

  45. MAUDES E, Planaguma J, Weber MS, Dalmau J, et al
    Animal models of autoimmune encephalitis.
    Curr Opin Immunol. 2025;95:102579.
    >> Share

  46. GUVENC F, Danska JS
    The intestinal microbiome in type 1 diabetes: bridging early childhood exposures with translational advances.
    Curr Opin Immunol. 2025;94:102553.
    >> Share

    May 2025
  47. CHEN J, Wang X
    Epigenetic regulation of B cell response in autoimmune diseases.
    Curr Opin Immunol. 2025;95:102582.
    >> Share

  48. LE PANSE R
    Is there a path to cure myasthenia gravis?
    Curr Opin Immunol. 2025;95:102577.
    >> Share

  49. KOLEV M, Kremer AE, Sokollik C, Gershwin ME, et al
    Unmet needs in autoimmune liver diseases.
    Curr Opin Immunol. 2025;95:102565.
    >> Share

    April 2025
  50. TAYLOR H, Uhlig HH, Powrie F
    Autoimmunity in inflammatory bowel disease: a holobiont perspective.
    Curr Opin Immunol. 2025;94:102557.
    >> Share

  51. SUN Y, Zhang Z, Jia K, Liu H, et al
    Autoimmune-related adverse events induced by immune checkpoint inhibitors.
    Curr Opin Immunol. 2025;94:102556.
    >> Share

  52. SAVVIDES CS, James EA, Buckner JH
    Rheumatoid arthritis - the role of T cells in this complex systemic autoimmune disease.
    Curr Opin Immunol. 2025;94:102555.
    >> Share

  53. WRIGHT RC, Campbell DJ, Levings MK
    Pharmacotherapeutic strategies to promote regulatory T cell function in autoimmunity.
    Curr Opin Immunol. 2025;94:102554.
    >> Share

  54. LOVELL CD, Anguera MC
    More X's, more problems: how contributions from the X chromosomes enhance female predisposition for autoimmunity.
    Curr Opin Immunol. 2025;93:102543.
    >> Share

  55. KRONENBERG M, Riffelmacher T
    Defenders or defectors: mucosal-associated invariant T cells in autoimmune diseases.
    Curr Opin Immunol. 2025;93:102542.
    >> Share

  56. SOWERBY JM, Rao DA
    T cell-B cell interactions in human autoimmune diseases.
    Curr Opin Immunol. 2025;93:102539.
    >> Share

    January 2025
  57. HAO K, Marshak-Rothstein A
    Nucleic acid triggers of autoimmunity and autoinflammation.
    Curr Opin Immunol. 2025;93:102535.
    >> Share

    December 2024
  58. HARM J, Fan YT, Brenner D
    Navigating the metabolic landscape of regulatory T cells: from autoimmune diseases to tumor microenvironments.
    Curr Opin Immunol. 2024;92:102511.
    >> Share

    September 2024
  59. HAMERMAN JA, Barton GM
    The path ahead for understanding Toll-like receptors-driven systemic autoimmunity.
    Curr Opin Immunol. 2024;91:102482.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016